Learn about the most important recent developments in breast cancer trials and FDA approvals.
Dr. Sara Hurvitz will share insights into key findings and discuss what the new evidence means for patients, caregivers, and clinical practice. The presentation will be followed by a moderated discussion and audience Q&A.